Newron Pharmaceuticals SpA’s (NWRN) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Newron Pharmaceuticals SpA is a Sell.
Newron Pharmaceuticals SpA’s (NWRN) 20-Day exponential moving average is 8.88, while Newron Pharmaceuticals SpA’s (NWRN) share price is CHF8.65, making it a Sell.
Newron Pharmaceuticals SpA’s (NWRN) 50-Day exponential moving average is 9.40, while Newron Pharmaceuticals SpA’s (NWRN) share price is CHF8.65, making it a Sell.
Newron Pharmaceuticals SpA’s (NWRN) 10-Day exponential moving average is 8.91, while Newron Pharmaceuticals SpA’s (NWRN) share price is CHF8.65, making it a Sell.
Newron Pharmaceuticals SpA’s (NWRN) 100-Day exponential moving average is 10.67, while Newron Pharmaceuticals SpA’s (NWRN) share price is CHF8.65, making it a Sell.
Newron Pharmaceuticals SpA’s (NWRN) stock price is CHF8.65 and Newron Pharmaceuticals SpA’s (NWRN) 50-day simple moving average is 9.25, creating a Sell signal.
Newron Pharmaceuticals SpA’s (NWRN) stock price is CHF8.65 and Newron Pharmaceuticals SpA’s (NWRN) 100-day simple moving average is 10.69, creating a Sell signal.
Newron Pharmaceuticals SpA’s (NWRN) stock price is CHF8.65 and Newron Pharmaceuticals SpA’s (NWRN) 200-day simple moving average is 13.16, creating a Sell signal.